IDEXX Laboratories Inc at Raymond James Institutional Investors Conference (Virtual) Transcript

Mar 01, 2021 / 02:10PM GMT
Andrew Harris Cooper - Raymond James & Associates, Inc., Research Division - Senior Research Associate

Sorry about that. Good morning, everyone. Welcome to the Raymond James Institutional Investor Conference. Thanks for joining us. I'm Andrew Cooper, and I cover animal health here for Raymond James. And we're excited to have IDEXX joining us this morning for a fireside chat.

Just some quick housekeeping. I'd love to include some questions from the audience today. (Operator Instructions)

Like I said, excited to have IDEXX, it's the largest player and, really, the leader in pretty much any sense of the word in animal diagnostics, which is one of the fastest-growing spaces in a really terrific end market.

With that, we have CEO, Jay Mazelsky here; as well as CFO, Brian McKeon. And Director of IR, John Ravis. And I'm going to jump right into some Q&A here.

Questions and Answers:

Andrew Harris Cooper - Raymond James & Associates, Inc., Research Division - Senior Research Associate

Maybe just to start with some high
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot